Stocks › SPNE

SPNE

SPNE·USD
—
No end-of-day price on record
SPNE
SPNE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
SPNES&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of SPNE by members of U.S. Congress · 1 on record
All congressional trades →
PoliticianStockTypeFiledTraded
James B. RenacciJames B. RenacciHouse · R · OH SPNESPNE · Stock Sale
$1,001 - $15,000
Jul 22, 2015 Jul 7, 2015 Filing ↗

Whale Activity

Position changes in SPNE reported for 2023-03-31 by 96 institutional filers
Closed: 96
  • Increased0
  • New0
  • Held0
  • Decreased0
  • Closed96
  • No prior filing0

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by SPNE insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

389 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Stephenson Kirtley C.Director Disposition to issuer −9,700 — — Jan 5, 2023 Form 4 ↗
Stephenson Kirtley C.Director Disposition to issuer −128.6K — — Jan 5, 2023 Form 4 ↗
Steinway AngelaDirector Disposition to issuer −23.7K — — Jan 5, 2023 Form 4 ↗
Maniar ShwetaDirector Disposition to issuer −24.0K — — Jan 5, 2023 Form 4 ↗
Gaeta ReneeDirector Disposition to issuer −36.1K — — Jan 5, 2023 Form 4 ↗
FEKETE MICHAELDirector Disposition to issuer −112.0K — — Jan 5, 2023 Form 4 ↗
HENNEMAN JOHN B IIIDirector Disposition to issuer −82.7K — — Jan 5, 2023 Form 4 ↗
BRADLEY KEITHDirector Disposition to issuer −88.6K — — Jan 5, 2023 Form 4 ↗
ESSIG STUARTDirector Disposition to issuer −460.3K — — Jan 5, 2023 Form 4 ↗
Winge John J.Vice President, Sales Disposition to issuer −91.0K — — Jan 5, 2023 Form 4 ↗
Lipschultz TylerSVP, Orthobiologics and BD Disposition to issuer −131.3K — — Jan 5, 2023 Form 4 ↗
Keran Patrick LSVP, General Counsel Disposition to issuer −69.6K — — Jan 5, 2023 Form 4 ↗
Cirino DennisSVP, Global Spinal Systems Disposition to issuer −48.6K — — Jan 5, 2023 Form 4 ↗
Benny Paul S.VP, Treasurer Disposition to issuer −20.9K — — Jan 5, 2023 Form 4 ↗
Bostjancic John J.Chief Financial Officer Disposition to issuer −102.6K — — Jan 5, 2023 Form 4 ↗
Valentine KeithChief Executive Officer · Director Disposition to issuer −333.8K — — Jan 5, 2023 Form 4 ↗
Winge John J.Vice President, Sales Tax withholding −2,490 $8.35 $21K Jan 1, 2023 Form 4 ↗
Winge John J.Vice President, Sales Option exercise +4,868 — — Jan 1, 2023 Form 4 ↗
Lipschultz TylerSVP, Orthobiologics and BD Tax withholding −3,411 $8.35 $28K Jan 1, 2023 Form 4 ↗
Lipschultz TylerSVP, Orthobiologics and BD Option exercise +8,362 — — Jan 1, 2023 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding SPNE · SEC Form N-PORT

No mutual fund or ETF has reported SPNE in an N-PORT filing in the last seven months.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming SPNE as client

No lobbying filings found naming SPNE as the client.

Government Contracts

Federal awards to SPNE · USAspending

No federal contract awards found for SPNE.

U.S. Patents

Recent USPTO applications naming SPNE

No USPTO patent applications found for SPNE.

Annual Financials

From SPNE's 10-K filings · XBRL

SPNE is not in SEC's company list, so there are no XBRL filings to show.

Stock Splits

Every split and reverse split in the price history

No price history on record for SPNE.

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About SPNE

From SEC EDGAR company records

No company profile on record.